多肽CRDMO平台
目录肽
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
ATPE-001A
Atriopeptin I (rat)
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Cys&Cys Bridge)
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Cys&Cys Bridge)
Size：0.5
P1(RMB)：680
MW：2083.29
One letter sequence：SSCFGGRIDRIGAQSGLGCNS(Cys&Cys bridge)
Molecular Formula：C83H135N29O30S2
Description：Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
Literature Reference：M.G.Currie et al., Science, 223, 67 (1984)
Cas：89139-53-7
P1(RMB)：680
MW：2083.29
One letter sequence：SSCFGGRIDRIGAQSGLGCNS(Cys&Cys bridge)
Molecular Formula：C83H135N29O30S2
Description：Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
Literature Reference：M.G.Currie et al., Science, 223, 67 (1984)
Cas：89139-53-7
